23 February 2021 : Original article
Kidney Function After Liver Transplantation in a Single Center
Grzegorz Niewiński1ADEFG, Wiktor Smyk2B, Agata Graczyńska1B, Konrad Kostrzewa3C, Joanna Raszeja-Wyszomirska2ADEF*, Urszula Ołdakowska-Jedynak4DF, Jolanta Małyszko4DF, Maciej Wójcicki2DF, Krzysztof Zieniewicz5DEFDOI: 10.12659/AOT.926928
Ann Transplant 2021; 26:e926928
Table 6 The features impacted the changes in the last recorded SCr during follow-up period.
| Δ crea (+) | Δ crea (−) | p-Value | |
|---|---|---|---|
| Age | 54.5±18.5 | 56.5±14.75 | 0.34 |
| Serum sodium before LT (mmol/L) | 138.5±4.9 | 140.65±4.8 | 0.077 |
| SCr before LT (mg/dL) | 0.79±0.315 | 1.245±1.195 | 0.000000122 |
| Colloids (mL) | 1000±700 | 950±500 | 0.38 |
| Crystalloids (mL) | 4000±1000 | 4000±1000 | 0.40 |
| Anhepatic phase (min) | 90±50 | 85±47.5 | 0.28 |
| Hypotonia (MAP ≤80 mmHg) (% of individuals) | 54 | 46 | 0.511 |
| Catecholamines usage during LT (n of patients) | 21 | 9 | 0.872 |
| Tacrolimus blood through level (ng/mL) | 9.35±6.4 | 8.6±9.3 | 0.257 |
| SCr – serum creatinine; MAP – mean arterial pressure. Data presented as median±IQR. | |||